NCT04034277

Brief Summary

The aim of the study is to identify the most effective method of intervention to reduce hypophonia in PwMS (Patient With Multiple Sclerosis), as a way to optimize the speech-therapy treatment based on scientific evidence. In the previous AB study, we aimed to verify the efficacy of LSVT LOUD® in PwSM: in the present study we will compare different treatment in a larger sample. Half of the participants will follow the LSVT Loud program, the other half will follow usual care rehabilitation programs. The results of these groups will be compared with an historical cohort of no treatment patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2018

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 24, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2020

Completed
Last Updated

July 26, 2019

Status Verified

July 1, 2019

Enrollment Period

1.7 years

First QC Date

July 24, 2019

Last Update Submit

July 24, 2019

Conditions

Keywords

Voice DisordersSpeech and language therapyLee Silverman voice treatment

Outcome Measures

Primary Outcomes (3)

  • Change in intensity (dB) of 3 sustained /ah/

    All subjects were requested to sustain the vowel /ah/ as long as possible at a comfortable frequency and maximum intensity level. Specific task was given: "Please and say /ah/. Make it strong and steady, and sustain it for as long as you can".

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

  • Change in intensity measured in decibel (dB) of three functional sentences

    all speakers were requested to produce three functional sentences at a comfortable frequency and maximum intensity level. The sentences were the same for all subjects. Specific tasks, identical for each individual, was given: "Please take a deep breath and repeat each sentences with effort voice".

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

  • Change in intensity in conversation measured in decibel (dB)

    A speech sample of approximately one minute of spontaneous conversation was recorded and measured in dB in order to analyze speech intensity. Specific tasks, identical for each individual, was given: "Please speak for at least a minute".

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

Secondary Outcomes (3)

  • Change in Maximum Phonation Time (MPT) of three sustained /ah/ (sec.)

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

  • Change in Vocal Handicap Index

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

  • Change in GIRBAS

    at baseline, at 4 weeks (after the completion of 16 training sessions) and after 6-12 months up to the end of the rehabilitation program (FU)

Study Arms (2)

Lee Silverman Voice Therapy

EXPERIMENTAL

LSVT LOUD® is a therapy program which requires four sessions per week for 4 weeks by a speech and language therapists with a certification in Lee Silverman Voice Therapy. Each session lasted 50-60 min.

Other: Lee Silverman Voice Therapy

Conventional Treatment

ACTIVE COMPARATOR

The content and dose of standard SLT is poorly defined within the published literature. For this reason, the standard therapy intervention will encompass all SLT techniques that are not LSVT®. Treatment will be individualized and may include any of the following: exercises targeting respiration, phonation, articulation, behavioral strategies to reduce prosodic abnormality

Other: Conventional Treatment

Interventions

LSVT LOUD® comprises maximum effort non-speech and speech drills. The non-speech drills include the production of 15 sustained 'ah' phonation at high volume and pitch glides (5 repetitions moving from modal pitch to high pitch and 15 repetitions moving from modal pitch and going down on production of sustained 'ah'). The speech drills utilize a hierarchy of speech tasks moving from single words through phrases and onto conversational speech to generalize

Lee Silverman Voice Therapy

speech rehabilitation protocol comprehend: * Respiratory and phonatory exercises: exercises to increase diaphragmatic and respiratory functions, exercises to increase expiration time using natural expiration or sibilant, exercise to increase phonation time by pronouncing the vocal /a/, exercise to reduce oral stiffness. * Articulation and prosody exercises: repetition or reading lists of possibly long and complex words that start with or contain consonants groups. Read aloud texts, sentences or words, making sure to articulate and pronounce the words well without diminishing or increasing the rhythm of speech, with the correct punctuation and intonation. If necessary, ask patients to hyperarticulate, accelerate or slow down, or exaggerate intonation.

Conventional Treatment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Multiple Sclerosis according with McDonald's criteria;
  • absence of relaps in the last month;
  • Mini Mental State Examination (MMSE) \> 21 score for a better understanding and adherence to the execution of the proposed exercises;
  • hypophonia (conversation \< 60 dB SPL- distance was kept equal at about 15 cm);
  • ability to understand the aims of the study and acceptance to sign an informed consent;
  • acceptance of the intensity of the treatment;
  • ability to understand the Italian language.

You may not qualify if:

  • Presence of other neurological disorders;
  • visual/hearing impairments hindering the rehabilitation program;
  • clinical history of laryngeal cancer, chemotherapy, radiotherapy, head and neck trauma or endotracheal intubation;
  • relapse or sudden changes in their MS symptoms within the previous 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Don Gnocchi Irccs

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisVoice DisordersCommunication Disorders

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Maria Carrozza, PhD

    Fondazione Don C. Gnocchi

    STUDY DIRECTOR

Central Study Contacts

Davide Cattaneo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Coordinator Larice Lab.

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 26, 2019

Study Start

January 15, 2018

Primary Completion

September 30, 2019

Study Completion

March 30, 2020

Last Updated

July 26, 2019

Record last verified: 2019-07

Locations